Sotac Pharmaceuticals
SOTAC · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 14, 2025

Stock Price vs Company Growth
1d
0.0%
1w
1.6%
1m
9.1%
3m
9.1%
all
9.2%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 136 0%
108
140
Company Overview

Sales
95.6 Cr
Growth: 21.8%
Profit after Tax
4.01 Cr
Growth: 29.6%
Micro Cap
151 Cr
P/E: 39.6x
Industry P/E: 33.2x
Fundamentals

Sales (Cr) ₹ 95.6
Growth 21.8%
EBITDA 9.7%
P/S 1.6x
Dividend 0.0%
P/E 39.6x
Book Value ₹ 42.3
PEG Ratio 1.9x
ROE 19.1%
P/B 3.3x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company specializes in the production of high-quality pharmaceutical products on a loan license or contract manufacturing basis. It has a diverse product portfolio that includes a wide range of pharmaceuticals, nutraceuticals, and food products. Key Events/Milestone/ Achievement2015: The company was incorporated as a private limited company under the name Sotac Pharmaceuticals Private Limited.
Belongs to (1 Indices)